Skip to main navigation menu Skip to main content Skip to site footer

Research Article

Vol. 11 No. 2 (2008)

The Delay in Diagnosis of Tuberculosis in the Monteregie region of Quebec, Canada

  • Caroline Lacroix
  • Philippe Martin
  • Sebastien Turcotte
  • Steven DeRoche
  • Vanessa Magluilo
  • Christine Lacroix
November 2, 2020


Introduction – Despite being more prevalent in developing countries, tuberculosis (TB) remains an important health problem in Canada. Long diagnosis delays of respiratory tuberculosis are associated with adverse consequences for the patient but also for the community. From a public health perspective, identification of factors associated with long delays of diagnosis could help reduce these delays. Objectives – 1)To describe diagnosis delays of respiratory tuberculosis in Monteregie 2)To identify the characteristics of patients and factors associated with longer diagnosis delays 3)To identify consequences of these delays Methods – The study is descriptive and transversal. Data were obtained from notifiable diseases files of the Public Health Department of the Health and Social Services Agency of Monteregie. The diagnosis delay was calculated using the first symptomatic date and the date of diagnosis. For continued variable analyses, Student t tests and an ANOVA test were done. For categorical variables, Pearson’s chi squared test and a Mann-Whitney test were done. Results – The average delay of diagnosis for the 115 cases studied was 92.2 days (CI 80.6-103.8). Weight loss and/or non specific general malaise were associated with a longer diagnosis delay. No association was found between the diagnosis delay and possible consequences of longer delays. Discussion and conclusion: Most patients had a diagnosis delay longer than two months. A larger study that would divide the total diagnosis delay into a patient delay and a suspicion delay (health care system delay) could permit a better identification of factors that favour long delays.


  1. Agence de la santé publique du Canada. Normes Canadiennes pour la lutte antituberculeuse 6e édition – 2007.
  2. Direction de la santé publique de la Monteregie, Bulletin Sentinelle, années 2003 à 2006.
  3. Agence de la santé publique du Canada. La tuberculose au Canada – 2006, prédiffusion.
  4. Southwick FS. Pulmonary infections. In: Southwick FS, editor. Infectious Diseases in 30 days. United states of America, McGraw Hill; 2003. P 107-153
  5. Zafran N, Heldal E, Pavlovic S, Vuckovic D, Boe J.Why do our patients die of active tuberculosis in the era of effective therapy? Tubercle and Lung Disease. 1994; 75(5): 329-333.
  6. Enarson D. Failure of diagnosis as a factor in tuberculosis mortality CMAJ. 1978; 118 : 1520-1522.
  7. Madebo T, Lindtjorn B. Delay in treatment of pulmonary Tuberculosis : An analysis of symptom duration among Ethiopian patients. Medscape General Medicine. 1999: E6.
  8. El-Sony A, Enarson D, Khamis A, Baraka O, Bjune G. Relations of grading of sputum smears with clinical features of tuberculosis in patients in routine practice in Sudan. Int J Tuberc Lung Dis. 2002; 6(2): 91-97.
  9. Storla DG. Yimer S. Bjune GA. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health. 2008; 8(1) : 15-22.
  10. Perron L, Levac E et al. Rapport annuel 2006 - Les maladies infectieuses en Montérégie, incluant les maladies à déclaration obligatoire (MADO). Agence de la santé et des services sociaux de la Montérégie, juin 2007.
  11. Lina Perron, Louise de la Boissière et al. Les maladies infectieuses en Montérégie, incluant les maladies à déclaration obligatoire (MADO) – Rapport annuel 2005. Agence de la santé et des services sociaux de la Montérégie, juin 2006.
  12. Éric Levac, Julie Loslier et al. Maladies à declaration obligatoire d’origine infectieuse – Rapport annuel 2004. Agence de développement de réseaux locaux de services de santé et de services sociaux, avril 2005.
  13. Publications/3Monographies_Orientations_Rapports/Maladies_transmissibles/dsp_pub_rap_mado_2004.pdf
  14. World Health Organisation. Communicable diseases, Tuberculosis.
  15. Fara MG, Rygh JH, Steen T.W, Selmer R, Heldal E, Bjune G. Patient and health care system delays in the start of tuberculosis treatment in Norway. BMC Infectious Diseases. 2006; 6(33).
  16. Gagliooti C, Resi D, Moro ML. Delay in the treatment of pulmonary TB in a changing demographic scenario, International Journal of Tuberculosis and Lung Disease. 2006;10(3): 305-309.
  17. Rodger A, Jaffar S, Paynter S, Hayward A, Carless J, Maguire H. Delay in the Diagnosis of Pulmonary Tuberculosis., London, 1998-2000 : Analysis of surveillance data. BMJ. 2003; 326(7395): 909-910.
  18. Sanz B, Blasco T. Variables associated with diagnostic delay in immigrant groups with tuberculosis in Madrid. International Journal of Tuberculosis and Lung Disease. 2007; 11(6): 639-646.


Download data is not yet available.